Petros Pharmaceuticals, Inc. Common Stock

$0.0070
+0.0001 (+1.77%)

Volume:

146.172K ($1.02K)

Market Capitalization:

-

Petros Pharmaceuticals Price Chart

Petros Pharmaceuticals Price Chart6:29 AM7:49 AM9:09 AM10:29 AM11:49 AM1:09 PM2:29 PM0.007200000.007016670.006833330.006650000.006466670.006283330.01

Petros Pharmaceuticals Volume Chart

Petros Pharmaceuticals Volume Chart6:29 AM7:49 AM9:09 AM10:29 AM11:49 AM1:09 PM2:29 PM60.00K51.43K42.86K34.29K25.72K17.14K8.57K

Petros Pharmaceuticals Market Segments

Regular Trading Hours

+0.0009(+14.75%)
Open$0.0061
Close$0.0070
Low$0.0061
Low Change0.0000 (0.00%)
High$0.0072
High Change+0.0011 (+18.03%)
Range$0.0011
Volume146.172K
Dollar Volume$1.02K

Premarket

*No Trades in Segment

After Hours Yesterday

*No Trades in Segment

Regular Trading Hours Yesterday

+0.0001(+1.15%)
Open$0.0068
Close$0.0069
Low$0.0061
Low Change-0.0007 (-10.29%)
High$0.0072
High Change+0.0004 (+5.88%)
Range$0.0011
Volume62.646K
Dollar Volume$430.88

Premarket Yesterday

*No Trades in Segment

Petros Pharmaceuticals Moving Averages

5 Day Moving Average (SMA5)$0.0069
10 Day Moving Average (SMA10)$0.0069
20 Day Moving Average (SMA20)$0.0071
50 Day Moving Average (SMA50)$0.0068
100 Day Moving Average (SMA100)$0.0073
200 Day Moving Average (SMA200)$0.0148

Petros Pharmaceuticals Statistics

Average Volume (30 Days)123.82K
P/E Ratio (Current).00
EPS (Current)-$11.69
Dividend Yield0.00%
Free Cash Flow-$3.15M
Cash Ratio0.80
Current Ratio1.30
Quick Ratio1.30
Debt to Equity0.00
Enterprise Value-$8.91M
EV to EBITDA-2.58
EV to Sales-12.28
Price to Book0.00
Price to Cash Flow
Price to Free Cash Flow
Price to Sales0.03
Return on Assets-1.42%
Return on Equity2.61%

Petros Pharmaceuticals Stock Splits

There have been 2 stock splits for Petros Pharmaceuticals (PTPI). The last reverse stock split occured on May 1, 2025 and reduced the outstanding shares at a ratio of 25:1.

DateTypeRatio
May 1, 2025Reverse25:1
Dec 1, 2022Reverse10:1

Petros Pharmaceuticals Dividends

There have been no dividends for Petros Pharmaceuticals (PTPI).